Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-30,060
Closed -$5.01M 73
2024
Q4
$5.01M Buy
30,060
+15,853
+112% +$2.82M 2.03% 17
2024
Q3
$2.42M Buy
+14,207
New +$2.06M 1.05% 30
2023
Q3
Sell
-9,230
Closed -$1.1M 76
2023
Q2
$1.1M Buy
+9,230
New +$954K 0.72% 39

Other funds holding ORCL

Geneva Partners's ORCL Position: Q1 2025 in Review

Geneva Partners sold out of Oracle (ORCL) in Q1 2025, closing a stake of 30,060 shares — an estimated $5.01M sold.

Geneva Partners first reported a position in ORCL in Q2 2023 and held it in 3 quarters. The position peaked at $5.01M in Q4 2024. 3,246 funds tracked by Wall St. Rank hold ORCL as of Q1 2025.

  • Geneva Partners reported no remaining Oracle position as of Q1 2025 after selling out during the quarter.
  • Geneva Partners sold 30,060 Oracle shares in Q1 2025, an estimated $5.01M.
  • Geneva Partners first reported a position in Oracle in Q2 2023 and held it in 3 quarters.
  • Geneva Partners's Oracle position peaked at $5.01M in Q4 2024.
  • 3,246 funds tracked by Wall St. Rank held Oracle as of Q1 2025.

Based on Geneva Partners's 13F filing for Q1 2025, filed 30 Apr 2025.